An analysis of the prevalence of HER2 and KRAS mutations, and ALK rearrangements and clinical outcomes in Cancer and Leukemia Group B [CALGB (Alliance)] trial 30406 in advanced non-small cell lung cancer (NSCLC)
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 8039
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- T. E. Stinchcombe L. M. Sholl X. Wang L. Gu M. A. Socinski S. J. Rodig M. Capelletti J. Crawford M. J. Edelman M. L. A. Villalona-Calero R. Kratzke E. E. Vokes V. A. Miller P. A. Janne
- Networks:
- Study
- Alliance-30406
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords: